| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 09/28/2006 | US20060217404 Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases |
| 09/28/2006 | US20060217399 Phenyl quinolines and their use as estrogenic agents |
| 09/28/2006 | US20060217396 Benzoylguanidine salt and hydrates thereof |
| 09/28/2006 | US20060217393 NK-1 receptor antagonists |
| 09/28/2006 | US20060217392 Novel heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity |
| 09/28/2006 | US20060217388 Phthalazine derivatives for treating inflammatory diseases |
| 09/28/2006 | US20060217379 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/28/2006 | US20060217374 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 09/28/2006 | US20060217372 Diaryl ethers as opioid receptor antagonist |
| 09/28/2006 | US20060217369 Antiproliferative agents; tyrosine kinase inhibitors; anticancer; diseases associated with signal transduction pathways operating through growth factor receptors; 4-amino-1-((4-(3-methoxyphenylamino) quinazolin-5-yl)methyl)-N-methylpiperidine-3-carboxamide |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | DE102005014628A1 New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders |
| 09/28/2006 | CA2602383A1 Substituted triazole derivatives as oxytocin antagonists |
| 09/28/2006 | CA2602194A1 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof |
| 09/28/2006 | CA2601424A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 09/28/2006 | CA2600531A1 Pyrimidine compounds and methods of use |
| 09/28/2006 | CA2600063A1 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 09/28/2006 | CA2598969A1 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents |
| 09/28/2006 | CA2580857A1 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1704145A1 Selective kinase inhibitors |
| 09/27/2006 | EP1704143A1 Malononitrile compound as pesticides |
| 09/27/2006 | EP1703908A1 Aryl sulfonamide compounds and uses related thereto |
| 09/27/2006 | EP1703906A1 Immuno inhibitory pyrazolone compounds |
| 09/27/2006 | EP1703905A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
| 09/27/2006 | EP1565445B1 Process for the preparation of imidazolyl compounds |
| 09/27/2006 | EP1546135B1 Novel synthesis of irbesartan |
| 09/27/2006 | EP1501826B1 Substituted indoles as alpha-1 agonists |
| 09/27/2006 | EP1421078B1 Indole derivatives as beta-3 adrenergic agonists for the treatment of type 2 diabetes |
| 09/27/2006 | EP1335906B1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
| 09/27/2006 | CN1839130A N-substituted pyrazolyl-amidyl-benzimidazolyl C-KIT inhibitors |
| 09/27/2006 | CN1838951A Bicycl 3.1.1]heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors |
| 09/27/2006 | CN1276918C Use of polymerized phthalocyanine compound as cell cathode catalyst with direct alcohols as fuel |
| 09/26/2006 | US7112680 Condensing a heterocyclic ketone or aldehyde with a 2-(NH2-NH-)benzimidazole, -oxazole or -thiazole; ribonucleotide reductase inhibitors; anticarcinogenic and -tumor agents; also useful against multidrug resistant cells |
| 09/26/2006 | US7112603 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/26/2006 | US7112600 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity |
| 09/26/2006 | US7112590 Anticoagulant for mammals |
| 09/26/2006 | US7112589 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 09/26/2006 | US7112587 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 09/26/2006 | US7112585 For therapy of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms |
| 09/21/2006 | WO2006099379A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| 09/21/2006 | WO2006098705A1 Process for producing biphenyl-tetrazole compounds |
| 09/21/2006 | WO2006097808A1 Benzimidazolone derivatives as cb2 receptor ligands |
| 09/21/2006 | WO2006097474A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | WO2006097441A1 Potassium channel modulating agents and their medical use |
| 09/21/2006 | WO2006097261A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 09/21/2006 | WO2006097121A1 Method for producing biphenyl-tetrazole compounds |
| 09/21/2006 | WO2006097030A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds |
| 09/21/2006 | WO2006079556A3 Substituted 5-phenyl pyrimidines i in therapy |
| 09/21/2006 | WO2006076710A3 Preparation of crude candesartan cilexetil |
| 09/21/2006 | WO2006073376A3 Preparation of irbesartan |
| 09/21/2006 | WO2006065590A3 Pyridine and pyrimidine antiviral compositions |
| 09/21/2006 | WO2006063813A3 3-arylalkyl-substituted and 3-heteroarylalkyl-substituted-1,2,4-triazin-5(2h)-ones |
| 09/21/2006 | WO2006055760A9 Triazole compounds that modulate hsp90 activity |
| 09/21/2006 | US20060211866 Process for the preparation of angiotensin receptor blockers and intermediates thereof |
| 09/21/2006 | US20060211865 Use of pyridine N-oxide analogs at doses which do not induce emesis |
| 09/21/2006 | US20060211861 Process for the preparation of opioid modulators |
| 09/21/2006 | US20060211759 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 09/21/2006 | US20060211738 Certain substituted diphenyl ureas, as modulators of kinase activity |
| 09/21/2006 | US20060211737 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 09/21/2006 | US20060211734 (Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists |
| 09/21/2006 | US20060211730 Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase |
| 09/21/2006 | US20060211728 Thalidomide analogs |
| 09/21/2006 | US20060211719 Heteroaryl aminoguanidine and alkoxyguanidines and their use as protease inhibitors |
| 09/21/2006 | US20060211717 Quinoline and quinazoline derivatives and drugs containing the same |
| 09/21/2006 | US20060211714 Quinazoline derivatives and their use in the treatment of cancer |
| 09/21/2006 | US20060211710 Substituted aryl 1,4-pyrazine derivatives |
| 09/21/2006 | US20060211709 Protein kinase modulators and methods of use |
| 09/21/2006 | US20060211707 Piperazine-alkyl-ureido derivatives |
| 09/21/2006 | US20060211706 e.g. 3-Bromo-8,11-dichloro-6,11-dihydro[5,6]cyclohepta[1,2-b]pyridine deivative; anticarcinogenic agents |
| 09/21/2006 | US20060211699 Quinoxaline dihydrohalide dihydrates and synthetic methods therefor |
| 09/21/2006 | US20060211698 Bicyclic heteroaryl derivatives for treating viruses |
| 09/21/2006 | US20060211693 Cis-imidazolines |
| 09/21/2006 | US20060211692 reacting cis-hydroxy-D-proline with 4-chlorophenyl iso-cyanate forming intermediate 1(4-chlorophenylcarbamoyl)-4-hydroxypyrrolidine-2-carboxylic acid, reacting intermediate with aminophenylmorpholinone; 1-[(4-chlorophenyl)]-2-{[4-(3-oxomorpholin-4-yl)phenyl]}-(2R)-pyrrolidine-1,2-dicarboxamide |
| 09/21/2006 | US20060211683 Erastin and erastin binding proteins, and uses thereof |
| 09/21/2006 | US20060211682 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 09/21/2006 | US20060211680 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 09/21/2006 | US20060211679 Substituted lactams as inhibitors of Abeta protein production |
| 09/21/2006 | US20060211577 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds |
| 09/21/2006 | US20060211565 Preparation of high nitrogen compound and materials therefrom |
| 09/21/2006 | US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 09/21/2006 | CA2601628A1 Certain substituted amides, method of making, and method of use thereof |
| 09/21/2006 | CA2601527A1 Potassium channel modulating agents and their medical use |
| 09/21/2006 | CA2599538A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | CA2599476A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1702917A1 Amide derivative and medicine |
| 09/20/2006 | EP1701954A1 N-substituted piperidine and piperazine derivatives |
| 09/20/2006 | EP1701950A1 Ecstasy haptens and immunogens |
| 09/20/2006 | EP1701945A1 Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof |
| 09/20/2006 | EP1701940A1 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
| 09/20/2006 | CN1835945A Chinazoline derivatives as aurora kinase inhibitors |
| 09/20/2006 | CN1835943A 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/20/2006 | CN1835924A Fused compounds that inhibit vanilloid receptor subtype 1(vr1) receptor |
| 09/20/2006 | CN1835756A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 09/20/2006 | CN1835753A Spiro tetrahydroquinazolines and dihydrocyclopentapyrimidines as CFR antagonists |
| 09/20/2006 | CN1835746A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |